Author

Jerren Ho

Aaron Diamond AIDS Research Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

David D. HoiD· 2 shared Qian WangiD· 2 shared Yicheng GuoiD· 2 shared Chih-Chen TzangiD· 1 shared Eswar R. ReddemiD· 1 shared Hsiang HongiD· 1 shared Ian A. MellisiD· 1 shared Jian YuiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

David D. HoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2

Qian Wang, Yicheng Guo, Ryan G. Casner, Jian Yu, Manoj S. Nair, Jerren Ho, Eswar R. Reddem, Ian A. Mellis, Madeline Wu, Chih-Chen Tzang, Hsiang Hong, Yaoxing Huang, Lawrence S. Shapiro, Lihong Liu, David D. Ho

This study optimizes a human monoclonal antibody to enhance its neutralization of SARS-CoV-2 variants, including subvariants XEC and LP.8.1, through structural analysis and engineering.

Nature Communications · Jul 4, 2025Peer-reviewedMicrobiology

Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages

Qian Wang, Yicheng Guo, Jerren Ho, David D. Ho

This study evaluates pemivibart's neutralizing activity against recent SARS-CoV-2 JN.1 sublineages and finds it has substantially reduced potency against KP.3.1.1.

bioRxiv · Aug 12, 2024 · PreprintImmunology